{"nctId":"NCT00427700","briefTitle":"Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome","startDateStruct":{"date":"2008-08"},"conditions":["Polycystic Ovary Syndrome"],"count":82,"armGroups":[{"label":"Clomiphene","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: clomiphene citrate"]},{"label":"Raloxifene","type":"EXPERIMENTAL","interventionNames":["Drug: raloxifene"]}],"interventions":[{"name":"clomiphene citrate","otherNames":["Clomid"]},{"name":"raloxifene","otherNames":["Evista"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* All patients with polycystic ovarian syndrome will be invited to participate in the study. The PCOS criteria are according to modified Rotterdam criteria (7); i.e., oligoovulation defined as \\< 6 menstrual periods per year, signs of clinical hyperandrogenism (Ferriman and Gallwey \\>8) or laboratorial (total Testosterone \\>=0.81 ng/dL) or polycystic ovary \\> 10cm3.\n\nFurthermore, all patients with infertility diagnosis based solely on ovulation factor will included in the protocol\n\n* Age \\>18 years old and \\<= 38 years old.\n* No endometriosis on laparoscopy\n\nExclusion Criteria:\n\n* Not willing to participate in the study\n* use of IUD or contraceptive pill within 2 months before the study.\n* Hyperprolactinemia (\\>20ng/mL)\n* Abnormal serum levels of TSH(normal range:0.4-40 mUI/mL).\n* High 17-OH progesterone (\\>=4.9ng/mL)\n* Endometriosis\n* Known allergy to clomiphene or raloxifene","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"38 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Participants With Ovulation Detected by Ultrasound","description":"Ovulation detected by ultrasound was defined as the percentage of a participants with ovulation detected by ultrasound, defined as the dominant follicle and its subsequent collapse. If a dominant follicle was not observed by day 21 after menses, the ovulation induction was considered to be a failure.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"52.5","spread":null},{"groupId":"OG001","value":"40.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Serum Levels of Progesterone","description":"The level of serum progesterone that indicated ovulation was considered to be 3 ng/mL or greater, on days 8 to 10 after ovulation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26.1","spread":null},{"groupId":"OG001","value":"40","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":40},"commonTop":["nausea","headache","abdominal bloating","pelvic pain"]}}}